Efficacy, safety, and dose comparison of degarelix for the treatment of prostate cancer: A systematic review and meta-analysis

Table 2 Methodological quality of included studies

Ref.	Adequate sequence generation	Adequate allocation concealment	Blinding	Incomplete outcome data addressed	Free of selective reporting
Axcrona et al[14]	Unclear	Unclear	High risk	Low risk	Low risk
Anderson et al[15]	Unclear	Unclear	High risk	Low risk	Low risk
Mason et al[16]	Unclear	Unclear	High risk	Low risk	Low risk
Klotz et al[11]	Validated computer program	Low risk	High risk	Low risk	Low risk
Ozono et al[10]	Central allocation	Low risk	High risk	Low risk	Low risk
Van Poppel et al[12]	Unclear	Unclear	High risk	Low risk	Low risk